Vivos (RDGL) Net Income Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.99% |
| Sep 30, 2025 | -30.20% |
| Jun 30, 2025 | -32.33% |
| Mar 31, 2025 | -18.30% |
| Dec 31, 2024 | -15.21% |
| Sep 30, 2024 | -4.28% |
| Jun 30, 2024 | -20.24% |
| Mar 31, 2024 | -18.76% |
| Dec 31, 2023 | -15.34% |
| Sep 30, 2023 | 52.26% |
| Jun 30, 2023 | 31.56% |
| Mar 31, 2023 | 22.73% |
| Dec 31, 2022 | 23.10% |
| Sep 30, 2022 | 31.66% |
| Jun 30, 2022 | 12.31% |
| Mar 31, 2022 | -10.92% |
| Dec 31, 2021 | -21.20% |
| Sep 30, 2021 | -5.22% |
| Jun 30, 2021 | 14.96% |
| Mar 31, 2021 | 45.15% |
| Dec 31, 2020 | -19.99% |
| Sep 30, 2020 | 44.31% |
| Jun 30, 2020 | -15.15% |
| Mar 31, 2020 | -17.38% |
| Dec 31, 2019 | 49.22% |
| Sep 30, 2019 | 5.04% |
| Jun 30, 2019 | 30.51% |
| Mar 31, 2019 | 26.25% |
| Dec 31, 2018 | 87.14% |
| Sep 30, 2018 | -94.99% |
| Jun 30, 2018 | -55.39% |
| Mar 31, 2018 | -8.28% |
| Dec 31, 2017 | 7.94% |
| Sep 30, 2017 | 4.69% |
| Jun 30, 2017 | 8.46% |
| Mar 31, 2017 | 17.66% |
| Dec 31, 2016 | 18.92% |
| Sep 30, 2016 | 23.57% |
| Jun 30, 2016 | -45.95% |
| Mar 31, 2016 | -50.45% |
| Dec 31, 2015 | 21.25% |
| Sep 30, 2015 | -16.46% |
| Jun 30, 2015 | 64.94% |